Naveenraj Solomon is an Oncology physician affiliated with Loma Linda University Medical Center. OpenAlex indexes 69 publications with 965 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11370 Anderson St
Suite 2100
Loma Linda, CA 923543450
Telephone
909-558-2822Registry record last updated 21 Dec 2017.
Clinical trials
- Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
Sponsor: Loma Linda University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- INTUITIVE SURGICAL, INC.Program year20251 payment
- Medtronic, Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Nonsteroidal Anti-inflammatory Drug100%Celecoxib100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fragmentation of care in breast cancer: greater than the sum of its parts
Breast Cancer Research and Treatment
2024 - Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic
Annals of Surgical Oncology
2024 - Does Preoperative MRI Reduce Positive Margins after Breast-Conserving Surgery?
Annals of Surgical Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Anees Razzouk, MD
Loma Linda University Medical Center
Gayathri Nagaraj, MD
Loma Linda University Medical Center
Chien-Shing Chen, MD
Loma Linda University Medical Center
Warren Boling, MD
Loma Linda University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”